Novo Nordisk (NVO) announced Friday a pivotal Phase 3 trial designed to test its weight loss therapy semaglutide on patients with a liver disease called metabolic dysfunction-associated ...

Man suffering from knee pain sitting sofa. A mature man massaging his painful knee. Man suffering from knee pain at home, closeup. Pain knee Weight-loss drugs can help obese people battle knee ...

FRIDAY, Nov. 1, 2024 (HealthDay News) -- The GLP-1 drug semaglutide can help obese people manage debilitating knee arthritis, a new trial has found. People who received weekly injections of ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window SAN DIEGO -- Semaglutide (Wegovy) reduced albuminuria in patients with overweight or obesity and chronic kidney disease ...

THE controversial bid by a section of the ruling party to push President Emmerson Mnangagwa to extend his constitutional two terms in office threatened to spoil the Zanu PF conference in Bulawayo ...

The demand for weight loss operations dropped sharply last year as the number of people opting for anti-obesity drugs such as Wegovy and Saxenda more than doubled, a study published Friday found.

Share on Pinterest Semaglutide, the active ingredient in Ozempic and Wegovy, may also help lower the risk of developing Alzheimer’s disease in people living with type 2 diabetes. damkaz/Getty ...

Semaglutide—the diabetes and weight-loss drug known by brand names like Ozempic and Wegovy—is continuing to show its potential to treat a wide range of other conditions. While recent studies ...

The high-profile semaglutide drugs Ozempic and Wegovy have changed how millions of adults manage type 2 diabetes and weight, respectively. Now many thousands of teenagers are being prescribed ...

But in the last few years, with the approval of GLP-1 drugs like Wegovy and Zepbound, more and more people are opting for obesity medicines over gold-standard surgical treatments. “On a ...